Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Study of Induction Treatment With Velcade and Dexamethasone for Previously Untreated Patients With Multiple Myeloma and Renal Failure
ClinicalTrials.gov study NCT01084837. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Diagnostic Pattern and Prognosis of Multiple Myeloma Patients With Myocardial Amyloidosis Were Evaluated by NMR Based Metabolomics
ClinicalTrials.gov study NCT05718401. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Panobinostat and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma
ClinicalTrials.gov study NCT00962507. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Selinexor Plus VRd in High Risk Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT05422027. IPD Sharing: YES. Countries: 1. Publications: 0.
Multiple Myeloma Minimal Residual Disease
ClinicalTrials.gov study NCT02627261. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase I Study Of Panobinostat/Lenalidomide/Bortezomib/Dex for Relapsed And Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01965353. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Protocol of the Combination of Bortezomib and Tipifarnib for Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00972712. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Neurocognitive and Neuroimaging Outcomes in Older Patients With Multiple Myeloma Treated With Autologous Stem Cell Transplantation
ClinicalTrials.gov study NCT03508765. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Safety and Efficacy Study of a Triplet Combination of MLN9708, Lenalidomide and Dexamethasone in the Initial Management of Multiple Myeloma (IFM2013-06)
ClinicalTrials.gov study NCT01936532. IPD Sharing: Not stated. Countries: 1. Publications: 0.
BCMA/CD3 BsAb in the Treatment of High-risk Smoldering Multiple Myeloma
ClinicalTrials.gov study NCT06745687. IPD Sharing: Not stated. Countries: 1. Publications: 0.
SOM230 LAR With Bortezomib and Dexamethasone for Refractory or Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT01329289. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anti-BCMA CAR-T Cell Therapy for the R/R Multiple Myeloma
ClinicalTrials.gov study NCT04637269. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of ENMD-2076 in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00806065. IPD Sharing: NO. Countries: 1. Publications: 0.
Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant
ClinicalTrials.gov study NCT05317416. IPD Sharing: YES. Countries: 27. Publications: 0.
Studying Common Genetic Mutations Related to Mucositis in Patients With Multiple Myeloma Receiving High-Dose Melphalan
ClinicalTrials.gov study NCT00602147. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and ASCT-related Symptom Burden Optimization of Tocilizumab in ASCT Following HD Melphalan Conditioning for Multiple Myeloma Patients
ClinicalTrials.gov study NCT05855122. IPD Sharing: NO. Countries: 1. Publications: 0.
A Pharmacodynamic Study of the Apheresis Product of Multiple Myeloma Patients Undergoing Quad-induction Followed by Motixafortide + G-CSF Mobilization
ClinicalTrials.gov study NCT06547112. IPD Sharing: NO. Countries: 1. Publications: 0.
Antithymocyte Globulin and Sirolimus in Treating Patients With Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT00317798. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of QLS32015 in Patients With Recurrent or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05920876. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dual-target CAR-T Cells (C-4-29) in the Treatment of Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04861480. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.